Table 4.

Multivariable regression analysis of the predictor variables for obesity and dysglycaemia among people living with HIV (PLWH)

Predictor variable	Obesity (BMI ≥ 30 kg/m2)		P value	Dysglycaemia*		P‐value
	OR	95% CI		OR	95% CI
Gender
Male	Reference			Reference
Female	0.88	0.54–1.44	0.611	0.33	0.20–0.54	< 0.001
Age (years)	1.00	0.99–1.02	0.643	1.04	1.03–1.06	< 0.001
Smoking
Never smoker	Reference			Reference
Current smoker	0.82	0.50–1.33	0.419	1.07	0.73–1.58	0.721
Ex‐smoker	1.76	1.13–2.74	0.013	0.93	0.64–1.36	0.714
Body mass index (kg/m2)	N/A			1.12	1.08–1.16	< 0.001
HIV transmission mode
Male‐to‐male sex	Reference			Reference
Heterosexual	2.69	1.74–4.16	< 0.001	1.38	0.94–2.03	0.105
Intravenous drug use	2.85	1.61–5.04	< 0.001	3.18	1.83–5.54	< 0.001
Unknown/other	1.27	0.30–5.40	0.744	0.43	0.12–1.59	0.206
CD4 nadir ≥ 350 cells/μL	0.60	0.38–0.94	0.026	1.40	0.97–2.01	0.072
Use of selected NRTIs in the past †	0.95	0.66–1.38	0.806	1.26	0.92–1.73	0.153

BMI, body mass index; OR, odds ratio; CI, confidence interval; NRTI, nucleoside reverse transcriptase inhibitor.

^*Dysglycaemia was defined as the presence of diabetes or impaired fasting glucose.

^†Didanosine, zidovudine or stavudine.